Molecular and Pharmacokinetic Rationale for the Use of Chelidonium majus L. in Wound Healing: An In Silico and In Vitro Validation
Molecules · 17.04.2026 · 31 (8) · 1320
DOI: 10.3390/molecules31081320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 17.04.2026. Verfasst von Ana Borges und 5 weiteren Autor:innen. Beteiligte Einrichtung: CIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal. Hauptthemen laut MEDLINE: Wound Healing, Chelidonium majus, Plant Extracts. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, national funds FCT/MCTES, FCT under the Scientific Employment Stimulus Program.
Themen: Wundversorgung
Abstract (Originalsprache)
Wound healing involves the coordinated regulation of inflammation, angiogenesis, and extracellular matrix remodeling, processes modulated by natural bioactives. In this context, Chelidonium majus L. (C. majus), a plant rich in alkaloids and flavonoids, remains mechanistically underexplored. This study, therefore, investigates its metabolites using an integrated computational–experimental approach and evaluates their applicability in sericin-based wound-healing systems. A curated database of 83 C. majus bioactive compounds was analyzed using cheminformatics and molecular docking against key wound-healing targets (iNOS, VEGF, MMP-3, and tyrosinase), followed by ADMET and toxicity prediction (StopTox). Selected plant–sericin formulations were subsequently evaluated for wound-healing activity using an in vitro fibroblast scratch assay. Docking revealed strong binding affinities for several metabolites, particularly protopine, kaempferol-3-rutinoside, cynaroside, hesperidin, quercetin-3-rhamnosylrutinoside, and vitexin, indicating multi-target modulation across inflammatory, proliferative, and remodeling phases of tissue repair. ADMET and toxicity analyses predicted favorable dermal safety and pharmacokinetic profiles for most compounds. Consistently, in vitro assays demonstrated that C. majus–sericin systems had fibroblast migration and wound closure in a concentration- and ratio-dependent manner, with improved healing kinetics observed at 150 µg/mL and for formulations containing higher relative proportions of both components. The experimental outcomes supported the pro-angiogenic and matrix-stabilizing mechanisms predicted in silico. Overall, C. majus metabolites exhibit polypharmacological wound-healing activity, supporting their integration into sericin-based systems as a promising strategy for topical therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
- Research Center for Active Living and Wellbeing (LiveWell), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
- Grupo de Investigación en Desarrollo y Evaluación de Formas Farmacéuticas y Sistemas de Liberación Controlada, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno s/n, 37007 Salamanca, Spain.
- Nutrition and Bromatology Group, Department of Analytical Chemistry and Food Science, Instituto de Agroecoloxía e Alimentación (IAA)-CITEXVI, Universidade de Vigo, 36310 Vigo, Spain.
- Grupo de Investigación en Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno s/n, 37007 Salamanca, Spain.
ORCID-Profile: Ana Borges, Carlos Seiti H Shiraishi, Rui M V Abreu, María Luisa Martín Calvo, Josiana A Vaz, Ricardo C Calhelha
Förderung
- Fundação para a Ciência e Tecnologia
- national funds FCT/MCTES
- FCT under the Scientific Employment Stimulus Program
- FCT project Wastesilk
Zitieren
APA
Borges, A., Shiraishi, C. S. H., Abreu, R. M. V., Martín Calvo, M. L., Vaz, J. A., & Calhelha, R. C. (2026). Molecular and Pharmacokinetic Rationale for the Use of Chelidonium majus L. in Wound Healing: An In Silico and In Vitro Validation. Molecules, 31(8), 1320. https://doi.org/10.3390/molecules31081320
Vancouver
Borges A, Shiraishi CSH, Abreu RMV, Martín Calvo ML, Vaz JA, Calhelha RC. Molecular and Pharmacokinetic Rationale for the Use of Chelidonium majus L. in Wound Healing: An In Silico and In Vitro Validation. Molecules. 2026;31(8):1320. doi:10.3390/molecules31081320
BibTeX
@article{Borges2026,
author = {Borges, Ana and Shiraishi, Carlos Seiti H and Abreu, Rui M V and Martín Calvo, María Luisa and Vaz, Josiana A and Calhelha, Ricardo C},
title = {Molecular and Pharmacokinetic Rationale for the Use of Chelidonium majus L. in Wound Healing: An In Silico and In Vitro Validation},
journal = {Molecules},
year = {2026},
volume = {31},
number = {8},
pages = {1320},
doi = {10.3390/molecules31081320}
}
EUVIMED